WallStSmart
ORIC

Oric Pharmaceuticals Inc

NASDAQ: ORIC · HEALTHCARE · BIOTECHNOLOGY

$8.99
-6.48% today

Updated 2026-06-05

Market cap
$856.09M
P/E ratio
P/S ratio
EPS (TTM)
$-1.39
Dividend yield
52W range
$7 – $15
Volume
2.0M

Oric Pharmaceuticals Inc (ORIC) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item201720182019202020212022202320242025
Operating cash flow$-20.83M$-20.68M$-23.53M$-45.27M$-59.54M$-75.14M$-85.69M$-112.66M$-113.37M
Capital expenditures$486000.00$525000.00$768000.00$667000.00$939000.00$2.08M$849000.00$1.19M$712000.00
Depreciation$900000.00$903000.00$1.03M$970000.00$897000.00$966000.00$1.03M$1.11M
Stock-based comp$217.00$469000.00$1.09M$5.28M$12.85M$14.46M$15.23M$20.21M$25.04M
Free cash flow$-21.32M$-21.21M$-24.30M$-45.94M$-60.48M$-77.22M$-86.54M$-113.85M$-114.08M
Investing cash flow$-292000.00$-508000.00$-768000.00$-215.96M$158.44M$-109.25M$-43.40M$22.14M
Financing cash flow$260000.00$38.01M$70.82M$250.51M$49.13M$25.23M$85.66M$126.55M
Dividends paid
Share repurchases
Debt repayment
Net change in cash$-10.71M$148.03M$-159.17M

Frequently asked questions

How much free cash flow does ORIC generate?

ORIC produced $-114.08M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is ORIC's balance sheet healthy?

ORIC holds $45.67M in cash and equivalents against — in long-term debt, on $384.36M of shareholder equity. That debt is best read against the cash flow the business throws off each year.